|
US2008038308A1
|
|
Silencing RNA molecules and their use in bone formation
|
|
US2006251629A1
|
|
Muscle-based grafts/implants
|
|
WO2006022662A1
|
|
Methods and apparatus for minimally invasive recovery of bone and/or other tissue
|
|
WO2005070439A1
|
|
Implant comprising a human muscle tissue matrix
|
|
US2005152880A1
|
|
Matrix composition for human grafts/implants
|
|
AU2003302016A8
|
|
Compositions and devices comprising or encoding the run x2 protein and method of use
|
|
AU2002329884A1
|
|
Processed soft tissue for topical or internal application
|
|
WO03013342A2
|
|
Materials and methods for improved bone tendon bone transplantation
|
|
WO03051236A1
|
|
Materials and methods for improved bone tendon bone transplantation
|
|
WO03004990A2
|
|
Quantitative in vitro bone induction assay
|
|
WO02067814A2
|
|
System for reconstituting pastes and methods of using same
|
|
AU2002252019A1
|
|
Selective uptake of materials by bone implants
|
|
WO02062404A2
|
|
Closure of ruptured tissue and bulking of tissue
|
|
WO02060343A2
|
|
Methods, instruments and kits for improved formation and use of bone implantation
|
|
CA2436162A1
|
|
Injectable porous bone graft materials
|
|
AU9119101A
|
|
Combination biological-non-biological material prosthetic implant and method
|
|
AU9291701A
|
|
Method of preparing and processing transplant tissue
|
|
AU2001288840B2
|
|
Assembled implant, including mixed-composition segment
|
|
CA2437763A1
|
|
Assembled implant, including mixed-composition segment
|
|
US6893462B2
|
|
Soft and calcified tissue implants
|
